PolyPid has introduced a new family of drug carriers - PolyPid based on a fusion between two known drug delivery systems: polymers and lipid-based systems.
The patented carrier can be tailored to small molecules, peptides, protein and nucleic acids-based drugs.
The PolyPid platform can be utilized to address numerous medical indications in various fields, such as orthopedics, urology, periodontal, anti-cancer/anti-fungal treatments and surgical accessories.
PolyPid technology helps to entrap a large variety of one or more biologically active molecules, and to release them at a pre-programmed rate for up to several months, all according to the desired clinical rate.
PolyPid-based solution BonyPid is a biodegradable bone void filler that is micro-coated with a PolyPid biodegradable formulation.
PolyPid chief technology officer Noam Emanuel said PolyPid is a drug carrier that will help pharmaceutical and biotech companies enhance their drugs and meet their challenges.